Table 1.

Patient Characteristics

		ET-1 Risk Group (fmol/ml)
Variable	Total Cohort (N=101)	Low (N=76) (0.12-1.15)	High (N=25) (1.16–5.14)
Age, mean (SD), years	67.0 (9.0)	66.4 (8.7)	69.2 (10.2)
Female	3.1%	2.6%	6.0%
Non White Race	8.8%	9.0%	8.0%
History of Hypertension	85%	83%	94%
Active smokers	14.3%	14.0%	14.6%
LVEF, mean (SD)	52.7 (9.6)	54 (8.6)	46.2 (11.2)
Obesity (BMI >30)	46.8%	49%	37%
Diabetes	30%	29%	32%
Mean BDI Score (SD)	8.1 (5.9)	7.44 (5.20)	10.77 (7.95)
Medications
Ace inhibitors	52%	48%	63%
Beta-Blockers	77%	78%	77%
Aspirin	67%	68%	63%
Calcium Channel Blocker	31%	30%	32%
Statins	89%	89%	89%

ET-1 = Endothelin-1

fm/ml = fentomole/milliliter

LVEF = left ventricular ejection fraction

BMI = body mass index

BDI = Beck Depression Inventory